RELX Plc
RELX Plc (RLXXF) Financial Performance & Income Statement Overview
Explore the financials of RELX Plc (RLXXF), including yearly and quarterly data on income, cash flow, and balance sheets.
RELX Plc (RLXXF) Income Statement & Financial Overview
Explore comprehensive income reports for RELX Plc RLXXF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $4.79B | $4.64B | $4.66B | $4.50B |
| Cost of Revenue | $1.82B | $1.61B | $1.75B | $1.74B |
| Gross Profit | $2.98B | $3.03B | $2.91B | $2.76B |
| Gross Profit Ratio | $0.62 | $0.65 | $0.62 | $0.61 |
| R&D Expenses | $0.00 | $177.00M | $330.00M | $161.00M |
| SG&A Expenses | $1.51B | $1.63B | $1.52B | $1.45B |
| Operating Expenses | $1.51B | $1.60B | $1.52B | $1.45B |
| Total Costs & Expenses | -$3.32B | $3.21B | $3.28B | $3.19B |
| Interest Income | $2.00M | $0.00 | $2.00M | $6.00M |
| Interest Expense | $166.00M | $133.00M | $181.00M | $142.00M |
| Depreciation & Amortization | $394.00M | -$310.00M | $401.00M | $355.00M |
| EBITDA | $1.80B | $1.12B | $1.78B | $1.66B |
| EBITDA Ratio | $0.38 | $0.24 | $0.38 | $0.37 |
| Operating Income | $1.47B | $1.43B | $1.38B | $1.31B |
| Operating Income Ratio | $0.31 | $0.31 | $0.30 | $0.29 |
| Other Income/Expenses (Net) | -$224.00M | -$136.00M | -$244.00M | -$199.00M |
| Income Before Tax | $1.25B | $1.29B | $1.14B | $1.11B |
| Income Before Tax Ratio | $0.26 | $0.28 | $0.24 | $0.25 |
| Income Tax Expense | $304.00M | $309.00M | $243.00M | $264.00M |
| Net Income | $949.00M | $985.00M | $907.00M | $874.00M |
| Net Income Ratio | $0.20 | $0.21 | $0.19 | $0.19 |
| EPS | $0.51 | $0.52 | $0.48 | $0.46 |
| Diluted EPS | $0.51 | $0.52 | $0.48 | $0.46 |
| Weighted Avg Shares Outstanding | $1.86B | $1.89B | $1.88B | $1.90B |
| Weighted Avg Shares Outstanding (Diluted) | $1.87B | $1.90B | $1.90B | $1.91B |
Over the past four quarters, RELX Plc demonstrated steady revenue growth, increasing from $4.50B in Q2 2023 to $4.79B in Q4 2024. Operating income reached $1.47B in Q4 2024, maintaining a consistent 31% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.80B, reflecting operational efficiency. Net income dropped to $949.00M, with EPS at $0.51. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan